Ahn Heui-June, Oh Ho-Suk, Ahn Yongchel, Lee Sang Jin, Kim Hyun Joong, Kim Moon Ho, Eom Dae-Woon, Kwak Jae Young, Han Myoung Sik, Song Jae Seok
Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
Department of Pathology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
Ann Coloproctol. 2014 Aug;30(4):175-81. doi: 10.3393/ac.2014.30.4.175. Epub 2014 Aug 26.
The aim of this study was to identify prognostic factors in stage IVB colorectal cancer in elderly patients, focusing on the influence of treatment modalities, including palliative chemotherapy and primary tumor resection.
A cohort of 64 patients aged over 65 years who presented with stage IVB colorectal cancer at the Gangneung Asan Hospital between July 1, 2001, and December 31, 2009, was analyzed. Demographics, tumor location, tumor grade, performance status, levels of carcinoembryonic antigen (CEA), level of aspartate aminotransferase (AST), and distant metastatic site at diagnosis were analyzed. Using the treatment histories, we analyzed the prognostic implications of palliative chemotherapy and surgical resection of the primary tumor retrospectively.
The cohort consisted of 30 male (46.9%) and 34 female patients (53.1%); the median age was 76.5 years. Primary tumor resection was done on 28 patients (43.8%); 36 patients (56.2%) were categorized in the nonresection group. The median survival times were 12.43 months in the resection group and 3.58 months in the nonresection group (P < 0.001). Gender, level of CEA, level of AST, Eastern Cooperative Oncology Group performance status, tumor location, and presence of liver metastasis also showed significant differences in overall survival. On multivariate analysis, male gender, higher level of CEA, higher AST level, and no primary tumor resection were independent poor prognostic factors. In particular, nonresection of the primary tumor was the most potent/poor prognostic factor in the elderly-patient study group (P = 0.001; 95% confidence interval, 2.33 to 21.99; hazard ratio, 7.16).
In stage IVB colorectal cancer in elderly patients, resection of the primary tumor may enhance survival.
本研究旨在确定老年IVB期结直肠癌的预后因素,重点关注包括姑息化疗和原发肿瘤切除在内的治疗方式的影响。
分析了2001年7月1日至2009年12月31日期间在江陵峨山医院就诊的64例年龄超过65岁的IVB期结直肠癌患者。分析了人口统计学、肿瘤位置、肿瘤分级、体能状态、癌胚抗原(CEA)水平、天冬氨酸转氨酶(AST)水平以及诊断时的远处转移部位。利用治疗史,我们回顾性分析了姑息化疗和原发肿瘤手术切除的预后意义。
该队列包括30名男性(46.9%)和34名女性患者(53.1%);中位年龄为76.5岁。28例患者(43.8%)进行了原发肿瘤切除;36例患者(56.2%)被归类为未切除组。切除组的中位生存时间为12.43个月,未切除组为3.58个月(P<0.001)。性别、CEA水平、AST水平、东部肿瘤协作组体能状态、肿瘤位置和肝转移的存在在总生存方面也显示出显著差异。多因素分析显示,男性、CEA水平较高、AST水平较高和未进行原发肿瘤切除是独立的不良预后因素。特别是,在老年患者研究组中,未切除原发肿瘤是最有力的/不良预后因素(P = 0.001;95%置信区间,2.33至21.99;风险比,7.16)。
在老年IVB期结直肠癌患者中,切除原发肿瘤可能提高生存率。